{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:29:59Z","timestamp":1793618999055,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.imbio.2026.153246","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:37:34Z","timestamp":1789688254000},"page":"153246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complement dysregulation in lupus nephritis: interplay of hypocomplementemia and complement-directed autoantibodies"],"prefix":"10.1016","volume":"231","author":[{"given":"Durga","family":"Chougule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrutha","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tukaram","family":"Jamale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Rajadhyaksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayali","family":"Thakare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9990-8059","authenticated-orcid":false,"given":"Vandana D.","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2026.153246_bb0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/medicina56090430","article-title":"Complement properdin determines disease activity in MRL\/lpr mice","volume":"56","author":"Alaridhee","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.imbio.2026.153246_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1655825","article-title":"Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritis","volume":"16","author":"Andrulli","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0015","doi-asserted-by":"crossref","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","article-title":"Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors","volume":"59","author":"Arnaud","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.imbio.2026.153246_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/biom13020367","article-title":"Complement as a biomarker for systemic lupus erythematosus","volume":"13","author":"Ayano","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.imbio.2026.153246_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1681\/ASN.2010060647","article-title":"Complement factor H deficiency accelerates development of lupus nephritis","volume":"22","author":"Bao","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2026.153246_bb0030","series-title":"Physiology, Complement Cascade, in: StatPearls","author":"Bardhan","year":"2025"},{"key":"10.1016\/j.imbio.2026.153246_bb0035","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2026.153246_bb0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ekir.2016.06.005","article-title":"Complement-mediated glomerular diseases: a tale of 3 pathways","volume":"1","author":"Bomback","year":"2016","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.imbio.2026.153246_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1410032","article-title":"Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review","volume":"15","author":"Calatroni","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-025-03536-5","article-title":"Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis","volume":"27","author":"Calatroni","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imbio.2026.153246_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156992","article-title":"A multifaceted approach to lupus nephritis: deciphering the interplay between adipokines, cytokines and complement proteins in disease pathogenesis","volume":"194","author":"Chougule","year":"2025","journal-title":"Cytokine"},{"key":"10.1016\/j.imbio.2026.153246_bb0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2016.99","article-title":"Anti-complement factor H-associated glomerulopathies","volume":"12","author":"Dragon-Durey","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.imbio.2026.153246_bb0065","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.semarthrit.2020.06.009","article-title":"The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort","volume":"50","author":"Durcan","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.imbio.2026.153246_bb0070","unstructured":"eGFR Calculator | National Kidney Foundation, (n.d.). https:\/\/www.kidney.org\/professionals\/gfr_calculator (accessed August 5, 2024)."},{"key":"10.1016\/j.imbio.2026.153246_bb0075","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1177\/0961203317709347","article-title":"Autoantibodies against complement components in systemic lupus erythematosus \u2013 role in the pathogenesis and clinical manifestations","volume":"26","author":"Hristova","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2026.153246_bb0080","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00467-024-06284-x","article-title":"Anti-factor B antibodies in atypical hemolytic uremic syndrome","volume":"39","author":"Khandelwal","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2026.153246_bb0085","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/rheumatology\/keae436","article-title":"Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease","volume":"64","author":"Kharouf","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.imbio.2026.153246_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2020.05.005","article-title":"Anti-complement factor H autoantibodies may be protective in lupus nephritis","volume":"508","author":"Li","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.imbio.2026.153246_bb0095","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12026-023-09396-y","article-title":"Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis","volume":"71","author":"Li","year":"2023","journal-title":"Immunol. Res."},{"key":"10.1016\/j.imbio.2026.153246_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00036","article-title":"Early components of the complement classical activation pathway in human systemic autoimmune diseases","volume":"7","author":"Lintner","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0110","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203320932219","article-title":"Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2026.153246_bb0115","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2016030343","article-title":"Anti-factor B and anti-C3b autoantibodies in C3 glomerulopathy and Ig-associated membranoproliferative GN","volume":"28","author":"Marinozzi","year":"2017","journal-title":"JASN"},{"key":"10.1016\/j.imbio.2026.153246_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.ki.5002118","article-title":"The ISN\/RPS 2003 classification of lupus nephritis: an assessment at 3 years","volume":"71","author":"Markowitz","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2026.153246_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molimm.2022.08.011","article-title":"Overview on the role of complement-specific autoantibodies in diseases","volume":"151","author":"Matola","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0135","first-page":"375","article-title":"Anti-factor H autoantibodies in patients with lupus nephritis","volume":"163","author":"Mihaylova","year":"2024","journal-title":"Med. Cl\u00edn. (Engl. Ed.)"},{"key":"10.1016\/j.imbio.2026.153246_bb0140","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1681\/ASN.2020020168","article-title":"Challenges in understanding acute postinfectious glomerulonephritis: are anti-factor B autoantibodies the answer?","volume":"31","author":"Noris","year":"2020","journal-title":"JASN"},{"key":"10.1016\/j.imbio.2026.153246_bb0145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.nefroe.2016.11.008","article-title":"Autoantibodies against alternative complement pathway proteins in renal pathologies","volume":"36","author":"Nozal","year":"2016","journal-title":"Nefrolog\u00eda (English Edition)"},{"key":"10.1016\/j.imbio.2026.153246_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12882-015-0032-6","article-title":"Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation","volume":"16","author":"Nozal","year":"2015","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.imbio.2026.153246_bb0155","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2026.153246_bb0160","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2026.153246_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350918","article-title":"Canonical and noncanonical functions of complement in systemic lupus erythematosus","volume":"54","author":"Pickering","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0170","first-page":"353","article-title":"Anti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients, Indian","volume":"22","author":"Pradhan","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/j.imbio.2026.153246_bb0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/cei.13443","article-title":"Clinical and functional consequences of anti-properdin autoantibodies in patients with lupus nephritis","volume":"201","author":"Radanova","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0180","series-title":"The Complement System","first-page":"133","article-title":"Detection of anti-C3b autoantibodies by ELISA","author":"Radanova","year":"2021"},{"key":"10.1016\/j.imbio.2026.153246_bb0185","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.3390\/ijms23169281","article-title":"Autoantibodies against complement classical pathway components C1q, C1r, C1s and C1-Inh in patients with lupus nephritis","volume":"23","author":"Radanova","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.imbio.2026.153246_bb0190","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.ekir.2022.09.012","article-title":"Persistent isolated C3 hypocomplementemia as a strong predictor of end-stage kidney disease in lupus nephritis","volume":"7","author":"Rossi","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.imbio.2026.153246_bb0195","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/0961203311415561","article-title":"Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis","volume":"20","author":"Sato","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2026.153246_bb0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.amjms.2017.01.005","article-title":"Complement alternative pathway's activation in patients with lupus nephritis","volume":"353","author":"Song","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.imbio.2026.153246_bb0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2369-14-63","article-title":"Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis","volume":"14","author":"Tan","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.imbio.2026.153246_bb0210","unstructured":"R: The R Project for Statistical Computing, (n.d.). https:\/\/www.r-project.org\/ (accessed September 12, 2025)."},{"key":"10.1016\/j.imbio.2026.153246_bb0215","article-title":"Clearing the complexity: immune complexes and their treatment in lupus nephritis","volume":"17","author":"Toong","year":"2011","journal-title":"IJNRD"},{"key":"10.1016\/j.imbio.2026.153246_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1279","article-title":"Autoantibodies against complement component C1q in systemic lupus erythematosus","volume":"10","author":"Trendelenburg","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0225","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.ekir.2024.01.052","article-title":"Clinical relevance of anti-C3 and anti-C4 autoantibodies in lupus nephritis","volume":"9","author":"Vasilev","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.imbio.2026.153246_bb0230","doi-asserted-by":"crossref","first-page":"25343","DOI":"10.1074\/jbc.M115.647008","article-title":"Functional characterization of autoantibodies against complement component C3 in patients with lupus nephritis","volume":"290","author":"Vasilev","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2026.153246_bb0235","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/rheumatology\/kes218","article-title":"Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis","volume":"51","author":"Wang","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.imbio.2026.153246_bb0240","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.164.2.786","article-title":"Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B","volume":"164","author":"Watanabe","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2026.153246_bb0245","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-021-00984-1","article-title":"A review of complement activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.imbio.2026.153246_bb0250","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/nep.14194","article-title":"Anti-C1q antibodies in lupus nephritis children with glomerular microthrombosis","volume":"28","author":"Zhang","year":"2023","journal-title":"Nephrology"},{"key":"10.1016\/j.imbio.2026.153246_bb0255","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/IJGM.S449509","article-title":"Anticardiolipin antibody plays a more important role than anti-\u03b22-glycoprotein I antibody in activating complement in patients with lupus nephritis","volume":"17","author":"Zhang","year":"2024","journal-title":"Int. J. Gen. Med."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:18:50Z","timestamp":1793618330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0171298526000926"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153246","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement dysregulation in lupus nephritis: interplay of hypocomplementemia and complement-directed autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153246"}}